Turnstone Biologics Announces U.S. FDA Acceptance of IND for Immunotherapy Targeting HPV Positive Cancers
TraceLink Achieves 69% Overall Revenue Growth in Q1 2018, Including 270% Revenue Growth in EMEA
Kensho Technologies, Acquired by S&P Global, Hits Early Milestone; Expands Private Company Data Offering to Clients
Beam Therapeutics Launched to Develop Harvard Base Editing Technology toward Precision Genetic Medicines
